BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3402574)

  • 1. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents.
    Glupczynski Y; Delmee M; Bruck C; Labbe M; Avesani V; Burette A
    Eur J Epidemiol; 1988 Jun; 4(2):154-7. PubMed ID: 3402574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.
    Shungu DL; Nalin DR; Gilman RH; Gadebusch HH; Cerami AT; Gill C; Weissberger B
    Antimicrob Agents Chemother; 1987 Jun; 31(6):949-50. PubMed ID: 3619429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
    McNulty CA; Dent J; Wise R
    Antimicrob Agents Chemother; 1985 Dec; 28(6):837-8. PubMed ID: 2935076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
    Andreasen JJ; Andersen LP
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):147-9. PubMed ID: 3591312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.
    Karmali MA; De Grandis S; Fleming PC
    Antimicrob Agents Chemother; 1981 Apr; 19(4):593-7. PubMed ID: 7247381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.
    McNulty CA; Dent JC
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):566-9. PubMed ID: 3141174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
    Simor AE; Ferro S; Low DE
    Antimicrob Agents Chemother; 1989 Jan; 33(1):108-9. PubMed ID: 2712542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics.
    Nagate T; Numata K; Hanada K; Kondo I
    J Clin Gastroenterol; 1990; 12 Suppl 1():S135-8. PubMed ID: 2212539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori).
    Van Caekenberghe DL; Breyssens J
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1429-30. PubMed ID: 3674850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.
    Goodwin CS; Blake P; Blincow E
    J Antimicrob Chemother; 1986 Mar; 17(3):309-14. PubMed ID: 3700291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Campylobacter jejuni to twenty-three antimicrobial agents.
    Shanker S; Sorrell TC
    Pathology; 1983 Jan; 15(1):61-3. PubMed ID: 6602320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.
    Lariviere LA; Gaudreau CL; Turgeon FF
    J Antimicrob Chemother; 1986 Dec; 18(6):681-5. PubMed ID: 3493235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents.
    Andreasen JJ
    Acta Pathol Microbiol Immunol Scand B; 1987 Jun; 95(3):189-92. PubMed ID: 3630712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents.
    Flores BM; Fennell CL; Holmes KK; Stamm WE
    Antimicrob Agents Chemother; 1985 Aug; 28(2):188-91. PubMed ID: 3834828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.
    Vanhoof R; Gordts B; Dierickx R; Coignau H; Butzler JP
    Antimicrob Agents Chemother; 1980 Jul; 18(1):118-21. PubMed ID: 7416738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs.
    Gebhart CJ; Ward GE; Kurtz HJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):55-9. PubMed ID: 3985597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.